W Cowens, S Shak, A Goddard… - US Patent App. 12/ …, 2011 - Google Patents (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0171633 A1 Cowens et al. (43) Pub. Date: Jul. 14, 2011 US 20llOl7l633Al (54) METHOD TO USE GENE EXPRESSION TO DETERMINE LIKELIHOOD OF CLINICAL OUTCOME OF RENAL CANCER (76) ...
R Macfarlane, DYC Heng, W Xie, JJ Knox… - Cancer, 2011 - Wiley Online Library Five hundred twenty-nine patients with mRCC who received sunitinib (n = 323), sorafenib (n = 165), or bevacizumab (n = 41) were included in this analysis. Patient characteristics included: 74% male, median age 61 years, and median GFR 60.1 mL/min/1.73 m 2 ... Related articles - All 2 versions
[HTML] from 171.66.121.246YJ Cho, A Tsherniak, P Tamayo… - Journal of Clinical …, 2011 - 171.66.121.246 Patients and Methods We profiled the mRNA transcriptome of 194 medulloblastomas and performed high-density single nucleotide polymorphism array and miRNA analysis on 115 and 98 of these, respectively. Non-negative matrix factorization–based clustering of mRNA ... Cited by 13 - Related articles - All 7 versions
K Østlie, RJ Franklin, OH Skjeldal… - Archives of Physical …, 2011 - Elsevier To describe physical function in adult acquired major upper-limb amputees (ULAs) by combining self-assessed arm function and physical measures obtained by clinical examinations; to estimate associations between background factors and self-assessed arm function in ULAs; and to ...
I Lossos, A Alencar, R Malumbres… - US Patent …, 2011 - freepatentsonline.com Assays, methods and kits for predicting survival outcome in a subject having diffuse large B-cell lymphoma (DLBCL) and for measuring a subject's response to DLBCL therapy involve specific miRNAs that are prognostic biomarkers for prediction of outcome of DLBCL patients. ... Cached
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
